Where Will Nu Holdings Stock Be in 2030?
Despite fast growth, high profitability and an extraordinary runway ahead,…
Sell
15
BKYI Quote, Financials, Valuation and Earnings
Last price:
$0.76
Seasonality move
:
2.96%
Day range:
$0.76 - $0.81
52-week range:
$0.52 - $3.68
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.15x
P/B ratio:
17.87x
Volume:
192.5K
Avg. volume:
355.1K
1-year change:
-64.8%
Market cap:
$2.4M
Revenue:
$7.8M
EPS (TTM):
-$6.13
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BKYI
BIO-key International
|
$2.5M | -$0.35 | 25.47% | -92.08% | $3.00 |
|
CIX
Compx International
|
-- | -- | -- | -- | -- |
|
IVDA
Iveda Solutions
|
$2.5M | -$0.40 | 186.45% | -60.98% | -- |
|
NSSC
NAPCO Security Technologies
|
$45.8M | $0.27 | -7.06% | -25% | $30.40 |
|
UUU
Universal Security Instruments
|
-- | -- | -- | -- | -- |
|
VRME
VerifyMe
|
$5.1M | -$0.07 | -11.59% | -40% | $1.63 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BKYI
BIO-key International
|
$0.76 | $3.00 | $2.4M | -- | $0.00 | 0% | 0.15x |
|
CIX
Compx International
|
$21.23 | -- | $261.5M | 15.73x | $0.30 | 5.65% | 1.79x |
|
IVDA
Iveda Solutions
|
$2.34 | -- | $6.2M | -- | $0.00 | 0% | 0.90x |
|
NSSC
NAPCO Security Technologies
|
$22.67 | $30.40 | $825.2M | 17.44x | $0.13 | 2.1% | 4.50x |
|
UUU
Universal Security Instruments
|
$1.78 | -- | $4.1M | -- | $0.00 | 0% | 0.19x |
|
VRME
VerifyMe
|
$0.67 | $1.63 | $8.3M | -- | $0.00 | 0% | 0.29x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BKYI
BIO-key International
|
94.73% | -2.013 | 80.13% | 0.64x |
|
CIX
Compx International
|
-- | 0.543 | -- | 4.75x |
|
IVDA
Iveda Solutions
|
12.77% | -5.377 | 21.33% | 1.85x |
|
NSSC
NAPCO Security Technologies
|
-- | 1.511 | 0.35% | 5.68x |
|
UUU
Universal Security Instruments
|
26.49% | -0.595 | 27.36% | 0.61x |
|
VRME
VerifyMe
|
16.2% | -4.021 | 13.78% | 1.46x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BKYI
BIO-key International
|
$1.7M | -$580.4K | -221.43% | -662.7% | -29.86% | -$1.3M |
|
CIX
Compx International
|
$11.1M | $4.9M | 10.38% | 10.38% | 12.7% | $7.1M |
|
IVDA
Iveda Solutions
|
$410.5K | -$601.8K | -54.37% | -60.54% | -23.71% | -$1.2M |
|
NSSC
NAPCO Security Technologies
|
$24.5M | $11.2M | 28.2% | 28.2% | 26.02% | $12.4M |
|
UUU
Universal Security Instruments
|
$1M | -$870.8K | -18.8% | -26.44% | -15.73% | $2.5M |
|
VRME
VerifyMe
|
$2.4M | -$287K | -27.79% | -33.15% | -6.27% | $399K |
BIO-key International vs. Competitors
-
Which has Higher Returns BKYI or CIX?
Compx International has a net margin of -34.45% compared to BIO-key International's net margin of 11.74%. BIO-key International's return on equity of -662.7% beat Compx International's return on equity of 10.38%.
Company Gross Margin Earnings Per Share Invested Capital BKYIBIO-key International78.32% -$0.39 $2.5M CIXCompx International28.8% $0.37 $146.1M -
What do Analysts Say About BKYI or CIX?
BIO-key International has a consensus price target of $3.00, signalling upside risk potential of 294.53%. On the other hand Compx International has an analysts' consensus of -- which suggests that it could grow by 23.63%. Given that BIO-key International has higher upside potential than Compx International, analysts believe BIO-key International is more attractive than Compx International.
Company Buy Ratings Hold Ratings Sell Ratings BKYIBIO-key International0 0 0 CIXCompx International0 0 0 -
Is BKYI or CIX More Risky?
BIO-key International has a beta of 0.493, which suggesting that the stock is 50.714% less volatile than S&P 500. In comparison Compx International has a beta of 0.940, suggesting its less volatile than the S&P 500 by 5.987%.
-
Which is a Better Dividend Stock BKYI or CIX?
BIO-key International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Compx International offers a yield of 5.65% to investors and pays a quarterly dividend of $0.30 per share. BIO-key International pays -- of its earnings as a dividend. Compx International pays out 237.64% of its earnings as a dividend.
-
Which has Better Financial Ratios BKYI or CIX?
BIO-key International quarterly revenues are $2.1M, which are smaller than Compx International quarterly revenues of $38.4M. BIO-key International's net income of -$739K is lower than Compx International's net income of $4.5M. Notably, BIO-key International's price-to-earnings ratio is -- while Compx International's PE ratio is 15.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BIO-key International is 0.15x versus 1.79x for Compx International. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BKYIBIO-key International0.15x -- $2.1M -$739K CIXCompx International1.79x 15.73x $38.4M $4.5M
-
Which has Higher Returns BKYI or IVDA?
Iveda Solutions has a net margin of -34.45% compared to BIO-key International's net margin of -23.14%. BIO-key International's return on equity of -662.7% beat Iveda Solutions's return on equity of -60.54%.
Company Gross Margin Earnings Per Share Invested Capital BKYIBIO-key International78.32% -$0.39 $2.5M IVDAIveda Solutions17.12% -$0.26 $6.4M -
What do Analysts Say About BKYI or IVDA?
BIO-key International has a consensus price target of $3.00, signalling upside risk potential of 294.53%. On the other hand Iveda Solutions has an analysts' consensus of -- which suggests that it could grow by 241.88%. Given that BIO-key International has higher upside potential than Iveda Solutions, analysts believe BIO-key International is more attractive than Iveda Solutions.
Company Buy Ratings Hold Ratings Sell Ratings BKYIBIO-key International0 0 0 IVDAIveda Solutions0 0 0 -
Is BKYI or IVDA More Risky?
BIO-key International has a beta of 0.493, which suggesting that the stock is 50.714% less volatile than S&P 500. In comparison Iveda Solutions has a beta of 0.990, suggesting its less volatile than the S&P 500 by 1.004%.
-
Which is a Better Dividend Stock BKYI or IVDA?
BIO-key International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Iveda Solutions offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BIO-key International pays -- of its earnings as a dividend. Iveda Solutions pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BKYI or IVDA?
BIO-key International quarterly revenues are $2.1M, which are smaller than Iveda Solutions quarterly revenues of $2.4M. BIO-key International's net income of -$739K is lower than Iveda Solutions's net income of -$555K. Notably, BIO-key International's price-to-earnings ratio is -- while Iveda Solutions's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BIO-key International is 0.15x versus 0.90x for Iveda Solutions. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BKYIBIO-key International0.15x -- $2.1M -$739K IVDAIveda Solutions0.90x -- $2.4M -$555K
-
Which has Higher Returns BKYI or NSSC?
NAPCO Security Technologies has a net margin of -34.45% compared to BIO-key International's net margin of 24.38%. BIO-key International's return on equity of -662.7% beat NAPCO Security Technologies's return on equity of 28.2%.
Company Gross Margin Earnings Per Share Invested Capital BKYIBIO-key International78.32% -$0.39 $2.5M NSSCNAPCO Security Technologies57.04% $0.28 $174.2M -
What do Analysts Say About BKYI or NSSC?
BIO-key International has a consensus price target of $3.00, signalling upside risk potential of 294.53%. On the other hand NAPCO Security Technologies has an analysts' consensus of $30.40 which suggests that it could grow by 34.1%. Given that BIO-key International has higher upside potential than NAPCO Security Technologies, analysts believe BIO-key International is more attractive than NAPCO Security Technologies.
Company Buy Ratings Hold Ratings Sell Ratings BKYIBIO-key International0 0 0 NSSCNAPCO Security Technologies2 2 0 -
Is BKYI or NSSC More Risky?
BIO-key International has a beta of 0.493, which suggesting that the stock is 50.714% less volatile than S&P 500. In comparison NAPCO Security Technologies has a beta of 1.513, suggesting its more volatile than the S&P 500 by 51.279%.
-
Which is a Better Dividend Stock BKYI or NSSC?
BIO-key International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NAPCO Security Technologies offers a yield of 2.1% to investors and pays a quarterly dividend of $0.13 per share. BIO-key International pays -- of its earnings as a dividend. NAPCO Security Technologies pays out 26.61% of its earnings as a dividend. NAPCO Security Technologies's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios BKYI or NSSC?
BIO-key International quarterly revenues are $2.1M, which are smaller than NAPCO Security Technologies quarterly revenues of $42.9M. BIO-key International's net income of -$739K is lower than NAPCO Security Technologies's net income of $10.5M. Notably, BIO-key International's price-to-earnings ratio is -- while NAPCO Security Technologies's PE ratio is 17.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BIO-key International is 0.15x versus 4.50x for NAPCO Security Technologies. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BKYIBIO-key International0.15x -- $2.1M -$739K NSSCNAPCO Security Technologies4.50x 17.44x $42.9M $10.5M
-
Which has Higher Returns BKYI or UUU?
Universal Security Instruments has a net margin of -34.45% compared to BIO-key International's net margin of -16.92%. BIO-key International's return on equity of -662.7% beat Universal Security Instruments's return on equity of -26.44%.
Company Gross Margin Earnings Per Share Invested Capital BKYIBIO-key International78.32% -$0.39 $2.5M UUUUniversal Security Instruments18.46% -$0.40 $5.7M -
What do Analysts Say About BKYI or UUU?
BIO-key International has a consensus price target of $3.00, signalling upside risk potential of 294.53%. On the other hand Universal Security Instruments has an analysts' consensus of -- which suggests that it could fall by --. Given that BIO-key International has higher upside potential than Universal Security Instruments, analysts believe BIO-key International is more attractive than Universal Security Instruments.
Company Buy Ratings Hold Ratings Sell Ratings BKYIBIO-key International0 0 0 UUUUniversal Security Instruments0 0 0 -
Is BKYI or UUU More Risky?
BIO-key International has a beta of 0.493, which suggesting that the stock is 50.714% less volatile than S&P 500. In comparison Universal Security Instruments has a beta of 0.351, suggesting its less volatile than the S&P 500 by 64.945%.
-
Which is a Better Dividend Stock BKYI or UUU?
BIO-key International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Universal Security Instruments offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BIO-key International pays -- of its earnings as a dividend. Universal Security Instruments pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BKYI or UUU?
BIO-key International quarterly revenues are $2.1M, which are smaller than Universal Security Instruments quarterly revenues of $5.5M. BIO-key International's net income of -$739K is higher than Universal Security Instruments's net income of -$936.6K. Notably, BIO-key International's price-to-earnings ratio is -- while Universal Security Instruments's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BIO-key International is 0.15x versus 0.19x for Universal Security Instruments. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BKYIBIO-key International0.15x -- $2.1M -$739K UUUUniversal Security Instruments0.19x -- $5.5M -$936.6K
-
Which has Higher Returns BKYI or VRME?
VerifyMe has a net margin of -34.45% compared to BIO-key International's net margin of -6.54%. BIO-key International's return on equity of -662.7% beat VerifyMe's return on equity of -33.15%.
Company Gross Margin Earnings Per Share Invested Capital BKYIBIO-key International78.32% -$0.39 $2.5M VRMEVerifyMe31.55% -$0.05 $12.2M -
What do Analysts Say About BKYI or VRME?
BIO-key International has a consensus price target of $3.00, signalling upside risk potential of 294.53%. On the other hand VerifyMe has an analysts' consensus of $1.63 which suggests that it could grow by 143.26%. Given that BIO-key International has higher upside potential than VerifyMe, analysts believe BIO-key International is more attractive than VerifyMe.
Company Buy Ratings Hold Ratings Sell Ratings BKYIBIO-key International0 0 0 VRMEVerifyMe0 0 0 -
Is BKYI or VRME More Risky?
BIO-key International has a beta of 0.493, which suggesting that the stock is 50.714% less volatile than S&P 500. In comparison VerifyMe has a beta of 0.532, suggesting its less volatile than the S&P 500 by 46.775%.
-
Which is a Better Dividend Stock BKYI or VRME?
BIO-key International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VerifyMe offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BIO-key International pays -- of its earnings as a dividend. VerifyMe pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BKYI or VRME?
BIO-key International quarterly revenues are $2.1M, which are smaller than VerifyMe quarterly revenues of $7.7M. BIO-key International's net income of -$739K is lower than VerifyMe's net income of -$501K. Notably, BIO-key International's price-to-earnings ratio is -- while VerifyMe's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BIO-key International is 0.15x versus 0.29x for VerifyMe. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BKYIBIO-key International0.15x -- $2.1M -$739K VRMEVerifyMe0.29x -- $7.7M -$501K
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is it Too Late to Buy United Airlines Stock?
United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…
3 Smartest Dividend Stocks to Buy Now
When the market entered a correction in February and March,…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
GATE alert for Apr 2
Marblegate Acquisition [GATE] is up 86.64% over the past day.
Buy
52
NUTX alert for Apr 2
Nutex Health [NUTX] is down 1.33% over the past day.
Buy
75
CORT alert for Apr 2
Corcept Therapeutics [CORT] is down 7.43% over the past day.
